A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGumusay, Ozge
dc.contributor.authorHuppert, Laura A.
dc.contributor.authorMagbanua, Mark Jesus M.
dc.contributor.authorWabl, Chiara A.
dc.contributor.authorAssefa, Michael
dc.contributor.authorChien, Amy Jo
dc.contributor.authorMelisko, Michelle E.
dc.contributor.authorMajure, Melanie C.
dc.contributor.authorMoasser, Mark
dc.contributor.authorPark, John
dc.contributor.authorRugo, Hope S.
dc.date.accessioned2025-10-16T15:14:26Z
dc.date.issued2024
dc.identifier.doi10.1007/s10549-023-07073-0
dc.identifier.otherWOS:001081072700001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6168
dc.publisherSPRINGER
dc.sourceBREAST CANCER RESEARCH AND TREATMENT
dc.subjectEribulin
dc.subjectCyclophosphamide
dc.subjectMetastatic breast cancer
dc.subjectChemotherapy
dc.titleA phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS